Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

GeneXpert

- PMLiVE

WHO to establish tuberculosis vaccine accelerator council

An estimated 10.6 million contracted TB in 2021, with the disease causing 1.6 million deaths

Sanofi reception

Sanofi’s Priftin cleared for latent tuberculosis in the US

FDA approves Priftin with isoniazid for patients aged two years and older

- PMLiVE

Researchers develop breath test for TB

Inhaled form of isoniazid could show almost instant results

- PMLiVE

J&J’s TB drug moves closer to US approval

Bedaquiline recommended as treatment for multidrug resistant forms of the disease

- PMLiVE

Global Fund sacks inspector general, moves to new funding model

Also brings in former US global AIDS coordinator Mark Dybul as executive director

- PMLiVE

GSK expands open-source research project in TB

Opens up compound library and extends data transparency project

GSK partners with Aeras on TB vaccine

Will begin phase II trials in Kenya, India and South Africa

- PMLiVE

Sanofi signs tuberculosis research deal with TB Alliance

Aims to shorten regimens and tackle drug-resistant forms of infection

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links